Atlas Trials

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Clinical trial NCT04535687 · COMPLETED

Trial details

NCT number
NCT04535687
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2020-12-17
Primary completion
2023-06-12
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.